Effects of high doses of 17β-estradiol and ovariectomy on 7,12-dimethylbenz[a] anthracene induced mammary carcinomas and dysplasias in neonatally androgenized female Sprague-Dawley rats

Journal of Toxicologic Pathology

Volumn 13, Issue 2, 2000, Pages 77-85

  Kawaguchi, Hiroaki ^a   Sato, Kenichi ^a   Omachi, Katsumi ^a   Funato, Mamoru ^a   Nagata, Ryoichi ^b   Yoshida, Hiroki ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b SHIN NIPPON BIOMEDICAL LABORATORIES LTD   (Japan)

Author keywords

17 estradiol; 7,12 dimethylbenz a anthracene; Mammary carcinoma; Mammary dysplasia; Progesterone; Rat

Indexed keywords

EID: 34250200492     PISSN: 09149198     EISSN: 09149198     Source Type: Journal    
DOI: 10.1293/tox.13.77     Document Type: Article

References (35)

1. Davis HH, Simons M, and Davis JB. Cystic disease of the breast: relationship to carcinoma. Cancer 1964; 17: 957-978.
2. Veronesi U and Pizzocaro G. Breast cancer in women subsequent to cystic disease of the breast. Surg Gynecol Obstet 1968; 126: 529-532.
3. Moskowitz M, Gartside P, Wirman JA, and McLaughlin C. Proliferative disorders of the breast as risk factors for breast cancer in a self-selected screened population: pathologic markers. Radiology 1980; 134: 289-291.
4. Dupont WD and Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 1985; 312: 146-151.
5. Romieu I, Hernandez-Avila M, Lazcano E, Lopez L, and Romero-Jaime R. Breast cancer and lactation history in Mexican women. Am J Epidemiol 1996; 143: 543-52.
6. Negri E, Braga C, La Vecchia C, Levi F, Talamini R, and Franceschi S. Lactation and the risk of breast cancer in an Italian population. Int J Cancer 1996; 67: 161-164.
7. Lethaby AE, O'Neil MA, Mason BH, Holdaway IM, and Harvey VJ. Overall survival from breast cancer in women pregnant or lactating at or after diagnosis. Int J Cancer 1996; 67: 751-755.
8. Stuver SO, Hsieh CC, Bertone E, and Trichopoulos D. The association between lactation and breast cancer in an international case-control study: a re-analysis by menopausal status. Int J Cancer 1997; 71: 166-169.
9. Minami Y, Ohuchi N, Fukao A, and Hisamichi S. Risk factors for breast cancer: a case-control study of screen-detected breast cancer in Miyagi Prefecture, Japan. Breast Cancer Res Treat 1997; 44: 225-233.
10. Freudenheim JL, Marshall JR, Vena JE, Moysich KB, Muti P, Laughlin R, Nemoto T, and Graham S. Lactation history and breast cancer risk. Am J Epidemiol 1997; 146: 932-8.
11. Gilliland FD, Hunt WC, Baumgartner KB, Crumley D, Nicholson CS, Fetherolf J, and Samet JM. Reproductive risk factors for breast cancer in Hispanic and non-Hispanic white women: The New Mexico Womens Health Study. Am J Epidemiol 1998; 148: 683-92.
12. Furberg H, Newman B, Moorman P, and Millikan R. Lactation and breast cancer risk. Int J Epidemiol 1999; 28: 396-402.
13. Newcomb PA, Egan KM, Titus-Ernstoff L, Trentham-Dietz A, Greenberg ER, Baron JA, Willett WC, and Stampfer MJ. Lactation in relation to postmenopausal breast cancer. Am J Epidemiol 1999; 150: 174-82.
14. Yoshida H and Fukunishi R. Effect of neonatal administration of sex steroids on 7,12-dimethylbenz[a]anthracene-induced mammary carcinoma and dysplasia in female sprague-dawley rats. Jpn J Cancer Res (Gann) 1978; 69: 627-631.
15. Yoshida H, Kadota A, and Fukunushi R. Pathology of early lesions of mammary carcinoma and mammary dysplasia induced by 7,12-dimethylbenz[a] anthracene in the neonatally androgenized sprague-dawley female rats. Virchows Arch B Cell Path 1980; 34: 33-41.
16. Yoshida H, Kadota A, Fukunushi R, and Matsumoto K. Induction of mammary dysplasia and mammary carcinoma in neonatally androgenized female rats by 7,12-dimethylbenz[a] anthracene. J Natl Cancer Inst 1980; 64: 1105-1112.
17. Yoshida H, Fukunushi R, Kato Y, and Matsumoto K. Progesterone-stimulated growth of mammary carcinomas induced by 7,12-dimethylbenz[a]anthracene in neonatally androgenized rats. J Natl Cancer Inst 1980; 65: 823-828.
18. Yoshida H and Fukunishi R. Effects of sex steroids on the development of 7,12-dimethylbenz[a]anthracene-induced mammary dysplasia in neonatally androgenized female rats. Jpn J Cancer Res (Gann) 1981; 72: 315-317.
19. Mainland D and Murray IM. Tables for use in fourfold contingency tests. Science 1952; 116: 591-594.
20. Barraclough CA. Production of anovulatory, sterile rats by single injections of testosterone propionate. Endocrinol 1961; 68: 62-67.
21. Swanson HE, Werff Ten Bosch, and J.J.van der. Sex differences in growth of rats and their modification by a single injection of testosterone propionate shortly after birth. J Endocrinol 1963; 26: 197-207.
22. Barraclough CA. Alterations in reproductive function following prenatal and early postnatal exposure to hormones. Adv Reprod Physiol 1968; 3: 81-112.
23. Trichopoulos D, MacMahon B, and Cole P. Menopause and breast cancer risk. J Natl Cancer Inst 1972; 48: 605-613.
24. Okasaki K, Omachi K, Sato K, Funato M, Nagata R, and Yoshida H. Growth inhibition of a high dose of 17β-estradiol and ovariectomy on 7,12-dimethylbenz[a]anthracene-induced mammary carcinomas in female rats. J Toxicol Pathol 1998; 11: 257-62.
25. Yoshida H, Fukuhara T, Yamashi S, Yoshida A, Fukuhishi R, Tsuji M, and Matsumoto K. Effect of pharmacological doses of estrogen on ovary-independent rat mammary carcinoma containing estrogen and progesterone receptors. Cancer Res 1983; 43: 2311-2316.
26. Yoshida H, Yoshida A, Yamada M, Yamanaka K, Kitamura Y, and Matsumoto K. Regression with secretory changes of ovary-independent rat mammary carcinoma by pharmacological doses of estrogen. Jpn J Cancer Res (Gann) 1985; 76: 771-778.
27. Ohi Y and Yoshida H. Influence of estrogen and progesterone on the induction of mammary carcinomas by 7,12-dimethylbenz[a] anthracene in ovariectomized rats. Virchows Arch B Cell Path 1992; 62: 365-370.
28. Sato K, Omachi K, Kawaguchi H, Funato M, Okasaki K, Nagata R, and Yoshida H. The effects of sex hormones on the induction of mammary carcinomas in male rats by pulse doses of 7,12-dimethylbenz[a]anthracene. J Toxicol Pathol 1999; 12: 35-40.
29. Walker NI, Bennett RE, and Kerr JFR. Cell death by apoptosis during involution of the lactating breast in mice and rats. Amer J Anatomy 1989; 185: 19-32.
30. Ota K, Yokoyama A, and Shinde Y. Effects of administration of oxytocin and prolactin on nucleic acids and phosphoprotein contents of mammary glands in lactating rats. Nature 1962; 195: 77-78.
31. Griffith DR and Turner CW. Hormonal control of mammary gland involution in the rat. Proc Soc Exp Biol Med 1962; 110: 485-487.
32. Jones EA. Changes in the enzyme pattern of the mammary gland of the lactating rat after hypophysectomy and weaning. Biochem J 1967; 103: 420-427
33. Richards RC and Benson GK. Structural changes associated with inhibition of involution of the mammary gland in the albino rat. J Endocrinol 1971; 51: 137-148.
34. Lloyd RV. Estrogen-induced hyperplasia and neoplasia in the rat anterior pituitary gland; an immunohistochemical study. Am J Pathol 1983; 113: 198-206.
35. Osamura RY and Watanabe K. Ultrastructural localization of prolactin in estrogen-induced prolactinoma of the rat pituitary; experimental models for the human prolactinomas and the effects of bromocriptine. Acta Pathol Jpn 1986; 36: 1131-1137.